Impact of high-sensitivity next-generation sequencing, measurable residual disease and subsequent stem cell transplant in patients receiving blinatumomab for MRD-positive B-cell acute lymphoblastic leukemia
Manuel Maroun, I. F. Khouri, Walid Macaron, Daniel Nguyen et al.
Journal
Haematologica
Topics
Acute Lymphoblastic Leukemia research
article
Impact of high-sensitivity next-generation sequencing, measurable residual disease and subsequent stem cell transplant in patients receiving blinatumomab for MRD-positive B-cell acute lymphoblastic leukemia
Manuel Maroun, I. F. Khouri, Walid Macaron, Daniel Nguyen, Omer Karrar, Elizabeth J. Shpall, Nicholas J. Short, Hagop M. Kantarjian, Partow Kebriaei, Farhad Ravandi, Cedric Nasnas, Fadi Haddad, Nitin Jain, Rebecca Garris, Elias Jabbour
article en
Abstract
No abstract available for this paper.
Publication Tag
Haematologica
Institutions
The University of Texas MD Anderson Cancer Center (US)